Emanuel F Petricoin Selected Research

Emanuel F Petricoin Research Topics

Disease

129	Neoplasms (Cancer) 03/2022 - 01/2002
29	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2002
17	Carcinogenesis 01/2020 - 01/2002
16	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
14	Ovarian Neoplasms (Ovarian Cancer) 08/2017 - 07/2002
13	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2003
10	Carcinoma (Carcinomatosis) 07/2021 - 02/2002
8	Adenocarcinoma 01/2022 - 04/2003
8	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 02/2012
8	Melanoma (Melanoma, Malignant) 01/2021 - 10/2008
6	Lung Neoplasms (Lung Cancer) 10/2021 - 10/2015
6	Infections 01/2021 - 11/2010
5	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 10/2008
4	Disease Progression 01/2021 - 11/2003
4	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 06/2007
3	Triple Negative Breast Neoplasms 03/2022 - 01/2017
3	Pathologic Complete Response 03/2022 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 02/2014
2	Tuberculosis (Tuberculoses) 09/2021 - 01/2020
2	Actinic Keratosis 01/2021 - 03/2012
2	Lyme Disease (Disease, Lyme) 11/2020 - 02/2011
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 11/2009
2	Fibrosis (Cirrhosis) 12/2018 - 01/2018
2	Non-alcoholic Fatty Liver Disease 12/2018 - 07/2007
2	Ovarian Epithelial Carcinoma 08/2017 - 01/2003
2	Skin Neoplasms (Skin Cancer) 11/2016 - 08/2015

Drug/Important Bio-Agent (IBA)

94	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2002
47	Biomarkers (Surrogate Marker)IBA 03/2022 - 07/2002
34	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
23	Phosphotransferases (Kinase)IBA 11/2021 - 05/2005
15	PhosphoproteinsIBA 01/2022 - 02/2005
14	ProteomeIBA 01/2021 - 01/2002
7	Biological ProductsIBA 10/2021 - 11/2003
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 09/2011
7	Peptides (Polypeptides)IBA 11/2020 - 03/2004
7	ErbB Receptors (EGF Receptor)IBA 08/2020 - 10/2008
5	Lapatinib (GW572016)FDA Link 11/2019 - 11/2009
5	EnzymesIBA 01/2015 - 09/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 08/2017
4	Hormones (Hormone)IBA 01/2022 - 03/2011
4	RNA (Ribonucleic Acid)IBA 07/2021 - 01/2003
4	Insulin (Novolin)FDA Link 01/2020 - 07/2007
4	TOR Serine-Threonine KinasesIBA 01/2019 - 04/2007
4	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2006
4	AntigensIBA 09/2016 - 06/2009
3	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2005
3	Trastuzumab (Herceptin)FDA Link 11/2021 - 07/2015
3	lipoarabinomannan (LAM)IBA 09/2021 - 12/2017
3	AntibodiesIBA 01/2021 - 01/2005
3	HydrogelsIBA 12/2020 - 02/2011
3	Estrogen ReceptorsIBA 08/2020 - 09/2006
3	Protein Kinases (Protein Kinase)IBA 01/2020 - 02/2011
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 10/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2003
3	Lactic Acid (Lactate)FDA LinkGeneric 07/2017 - 07/2012
3	Drug CombinationsIBA 06/2017 - 07/2015
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2016 - 09/2003
3	Protein Isoforms (Isoforms)IBA 01/2015 - 01/2005
3	Pyruvate KinaseIBA 01/2015 - 11/2012
3	AlbuminsIBA 11/2011 - 01/2004
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2022 - 04/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	AnthelminticsIBA 11/2021 - 02/2017
2	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 10/2017
2	LigandsIBA 10/2021 - 11/2019
2	EpitopesIBA 09/2021 - 01/2020
2	BMS 754807IBA 01/2021 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2011
2	Blood Proteins (Serum Proteins)IBA 12/2020 - 01/2011
2	IntegrinsIBA 12/2020 - 06/2013
2	Complement System Proteins (Complement)IBA 12/2020 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 07/2015
2	MK 2206IBA 01/2020 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 01/2017
2	CollagenIBA 12/2018 - 05/2005
2	Toll-Like Receptor 4IBA 01/2018 - 11/2016
2	CytochromesIBA 10/2017 - 10/2017
2	BiguanidesIBA 10/2017 - 10/2017
2	Heme (Haem)IBA 10/2017 - 10/2017
2	Oxygen (Dioxygen)IBA 07/2017 - 07/2012
2	Phosphopyruvate Hydratase (Enolase)IBA 02/2016 - 06/2010
2	tyrosine receptor (receptor, tyrosine)IBA 10/2015 - 01/2015
2	Mitogen-Activated Protein KinasesIBA 01/2015 - 08/2009
2	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 05/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2012 - 07/2012
2	Glutamine (L-Glutamine)FDA Link 11/2012 - 02/2012
2	MitogensIBA 03/2012 - 02/2011

Therapy/Procedure

54	Therapeutics 01/2022 - 08/2002
23	Lasers (Laser) 10/2021 - 02/2002
8	Precision Medicine 10/2021 - 05/2010
6	Drug Therapy (Chemotherapy) 08/2020 - 11/2009
3	Neoadjuvant Therapy 10/2021 - 02/2007
3	Immunotherapy 01/2021 - 06/2009
3	Molecular Targeted Therapy 02/2011 - 03/2005
2	Radiotherapy 01/2022 - 01/2018
2	Oral Administration 11/2021 - 01/2017
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 04/2007